Full Schedule

Speaker: Marc S. Raab, MD (he/him/his) – Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Speaker: Charlotte Pawlyn, PhD, FRCP, FRCPath – The Institute of Cancer Research

Speaker: Enrique M. Ocio, MD, PhD – Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain

Speaker: Adam S. Sperling, MD, PhD (he/him/his) – Brigham and Women's Hospital

Speaker: Ashutosh D. Wechalekar, MD – University College Hospital

Speaker: Vaishali Sanchorawala, MD (she/her/hers) – Boston University Chobanian & Avedisian School of Medicine

Speaker: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Speaker: Efstathios Kastritis, MD, PhD (he/him/his) – National and Kapodistrian University of Athens

Speaker: Pankaj Malhorta, MD – Postgraduate Institute of Medical Education and Research

Speaker: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Speaker: Lalit Kumar, MD, DM (he/him/his) – Oncology and BMT, Artemis Hospitals, Gurugram122001, India

Speaker: Craig E. Cole, MD – Michigan State University-Karmanos Cancer Institute

Speaker: Nelson Leung, MD – Division of hematology and Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

Co-Chair: Pieter Sonneveld, MD, PhD (he/him/his) – EMN

Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Speaker: Paolo Ghia, MD. PhD (he/him/his) – Università Vita-Salute San Raffaele

Speaker: Jacqueline Cloos, PhD (she/her/hers) – Amsterdam UMC, location VUMC, Cancer Center Amsterdam

Speaker: Nicole Gormley, MD – U.S. Food and Drug Administration

Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Speaker: Mala Shanmugam, MS, PhD (she/her/hers) – Winship Cancer Institute, Emory University

Speaker: Felipe Prosper, MD (he/him/his) – Clinica Universidad de Navarra

Speaker: Arun P. Wiita, MD, PhD – University of California San Francisco, San Francisco, CA, USA

Speaker: Maximilian Merz, MD (he/him/his) – University of Leipzig

Speaker: Laura Lucia Cogrossi – San Raffaele Scientific Institute

Speaker: Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy

Speaker: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center

Panelist: Sonja Zweegman, MD, PhD – Amsterdam UMC

Panelist: Herve Avet-Loiseau, MD, PhD (he/him/his) – IUC-Oncopole

Panelist: Wilson I. Gonsalves, MD – Mayo Clinic, Rochester

Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium

Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium

Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium

Speaker: Roberto Mina, MD – European Myeloma Network, Italy

Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France

Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Lawrence Boise, PhD (he/him/his) – Emory University

Speaker: Suzanne Lentzsch, MD, PhD (she/her/hers) – Columbia University

Speaker: Paula Rodriguez-Otero, MD PhD (she/her/hers) – Clinica Universidad de Navarra

Speaker: Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute

Speaker: Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg

Speaker: Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany

Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Panelist: P. Joy Ho, MBBS DPhil FRACP FRCPA (she/her/hers) – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Keith Stewart, MB ChB – Princess Margaret Cancer Centre, University Health Network

Panelist: MELETIOS DIMOPOULOS, MD (he/him/his) – Department of Clinical Therapeutics/Medical School/National and Kapodistrian University of Athens

Panelist: Donna E. Reece, MD – University Health Network, Princess Margaret Cancer Centre

Panelist: Ajai Chari, MD, PhD – University of California, San Francisco

Panelist: Bindu Kanapuru

Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece

Speaker: Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre

Speaker: Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University

Speaker: Meral Beksac, MD (she/her/hers) – Ankara University

Speaker: Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences

Speaker: Cyrille Touzeau, MD, PhD – CHU Nantes

Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA

Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University

Speaker: Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA

Speaker: Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US

Speaker: Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute

Speaker: Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College